"Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approvalofitsAbbreviated New Drug Application (ANDA) fordoxycycline hyclate immediate release (IR) tablets(75mgand 150 mg)in the United States.Mayne Pharma has immediately commenced commercial launch to customers in the US."
Ann: FDA approval and first generic launch of Acticlate tablets, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.34 |
Change
0.140(2.69%) |
Mkt cap ! $433.8M | |||
| Open | High | Low | Value | Volume |
| $5.21 | $5.35 | $5.21 | $960.3K | 181.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9750 | $5.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.35 | 17260 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |